Several drugs already used in chemotherapy to suppress tumor growth, including sorafenib [65], dovitinib [66] and the Mcl-1 inhibitor SC-2001 [67, 68], exert their antitumor effects by enhancing the phosphatase activity of Shp1 on the transcriptional factor STAT3 [28]. Here, MCL1 is linked to neoplasm.